Parkinson's Disease Treatment Breakthrough With Therapeutic Cloning
A new research on Parkinson's Disease treatment proves to be successful in mice. There is still some work to do, but the new research using therapeutic cloning to treat Parkinson's disease may provide future avenues for treatment of the disease in humans.
Research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson's disease in mice. The study's results on Parkinson's disease treatment in mice with therapeutic cloning